RELMADA THERAPEUTICS, INC. (RLMD) Free cash flow 2016–2020
RELMADA THERAPEUTICS, INC. (RLMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$209.9MFY2020 · since FY2016: -$6.5M → -$209.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -$209.9M | -116.5% |
| FY2019 | -$96.9M | — |
| FY2017 | -$6.0M | +7.7% |
| FY2016 | -$6.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice